TrialThe Journal of clinical endocrinology and metabolism2002

Effect of fluvastatin slow-release on low density lipoprotein (LDL) subfractions in patients with type 2 diabetes mellitus: baseline LDL profile determines specific mode of action.

Karl Winkler et al.PubMed ↗Publisher ↗

No numbers read from the abstract.